IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
暂无分享,去创建一个
J. Trowsdale | R. Phillips | A. Sewell | V. Cerundolo | U. Gileadi | J Trowsdale | V Cerundolo | A K Sewell | D A Price | R E Phillips | B. Booth | B L Booth | U Gileadi | H Teisserenc | F M Flavin | F. Flavin | H. Teisserenc | D. Price
[1] K. Tanaka,et al. Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma , 1996, The Journal of experimental medicine.
[2] A. Goldberg,et al. Lactacystin and clasto-Lactacystin β-Lactone Modify Multiple Proteasome β-Subunits and Inhibit Intracellular Protein Degradation and Major Histocompatibility Complex Class I Antigen Presentation* , 1997, The Journal of Biological Chemistry.
[3] P. Kloetzel,et al. Inactivation of a Defined Active Site in the Mouse 20S Proteasome Complex Enhances Major Histocompatibility Complex Class I Antigen Presentation of a Murine Cytomegalovirus Protein , 1998, The Journal of experimental medicine.
[4] 久松浩. Newly Identified Pair of Proteasomal Subunits Regulated Reciprocally by Interferon γ , 1997 .
[5] B. Walker,et al. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. , 1996, The Journal of infectious diseases.
[6] S. Schreiber,et al. A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] R F Standaert,et al. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.
[8] P. Earl,et al. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. , 1988, Virology.
[9] L. Kaer,et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. , 1998 .
[10] R. Young,et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.
[11] A. Goldberg,et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.
[12] P. Boyer,et al. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1 , 1992, Journal of virology.
[13] Marian Orlowski,et al. Bovine Spleen Multicatalytic Proteinase Complex (Proteasome) , 1997, The Journal of Biological Chemistry.
[14] K. Rajewsky,et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.
[15] R. Phillips,et al. Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides , 1997, European journal of immunology.
[16] K Eichmann,et al. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.
[17] R. Demars,et al. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. , 1984, Human immunology.
[18] S. Tonegawa,et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.
[19] M. Bogyo,et al. A proteolytic system that compensates for loss of proteasome function , 1998, Nature.
[20] J. Trowsdale,et al. Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins , 1994, Current Biology.
[21] J. Yewdell,et al. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. , 1998, Journal of immunology.
[22] J. Yewdell,et al. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? , 1997, Journal of immunology.
[23] Marcus Groettrup,et al. Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ , 1995, European journal of immunology.
[24] J. Neefjes,et al. The proteasome‐specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells , 1997, European journal of immunology.
[25] R. Phillips,et al. Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation , 1997, The Journal of experimental medicine.
[26] R M Zinkernagel,et al. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. Elliott,et al. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport , 1995, European journal of immunology.
[28] S. Rowland-Jones,et al. Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes , 1998, Current Biology.
[29] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[30] J. Shabanowitz,et al. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. , 1998, Journal of immunology.
[31] D. Finley,et al. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome , 1993, Nature.